To validate IL-19 as an immunosuppressive cytokine that affects antitumor immunity, as indicated by the results of the human GBM tissue analysis, we applied IL-19 antibody treatment to block IL-19 function in GBM-bearing mice and examined survival outcomes and tumor growth. Here, IL19 is linked to neoplasm.